ArticleCancer immunology, immunotherapy : CII2023

PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model.

Xin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.